Welcome to our dedicated page for FOXO TECHNOLOGIES news (Ticker: FOXO), a resource for investors and traders seeking the latest updates and insights on FOXO TECHNOLOGIES stock.
FOXO Technologies Inc. (FOXO) generates news across healthcare services, behavioral health, biospecimen sourcing and biotechnology. Company announcements describe operations at its critical access hospital in East Tennessee, its behavioral health subsidiary, Myrtle Recovery Centers, its biospecimen provider Vector BioSource, Inc., and its biotechnology arm, FOXO Labs, Inc.
News items for FOXO often cover developments at Big South Fork Medical Center, including service expansions such as swing bed and wound care services and agreements like its Performance Network Agreement with Covenant Health to provide swing bed services within a broader performance network. Updates may also highlight patient volumes, service mix and new clinical offerings at the hospital.
FOXO’s behavioral health subsidiary, Myrtle Recovery Centers, Inc., appears frequently in company communications through license renewals, operational updates, and recognition from local and statewide organizations. News has included approval to receive Scott County Opioid Abatement Funds to support care for uninsured patients, as well as acknowledgments from associations such as the Rural Health Association of Tennessee.
On the life sciences side, FOXO issues press releases about its acquisition and growth of Vector BioSource, Inc., an information, data and biospecimen sourcing provider serving biotechnology, clinical research and pharmaceutical research sectors. These updates detail acquisition terms, revenue run-rate information, and planned funding for Vector’s growth initiatives.
FOXO also publishes news about FOXO Labs, Inc. and its epigenetics business, including the decision to pursue a spin-off of FOXO Labs, descriptions of its patent related to DNA epigenetic data, and its work on epigenetic biomarkers and AI-based wellness coaching concepts.
Corporate-level news for FOXO includes reverse stock split actions, changes to authorized share capital, preferred stock designations, and listing status updates, such as the transition of its common stock trading from NYSE American to the OTC market. Investors and observers can use the FOXO news feed on Stock Titan to follow these healthcare, biotechnology and corporate governance developments as they are disclosed in press releases and related SEC filings.
FOXO Technologies (NYSE American: FOXO) has announced a 1-for-1.99 reverse stock split of its Class A common stock, effective July 27, 2025, at 4:01 PM ET. The stock will begin trading on a split-adjusted basis on July 28, 2025, under the same symbol but with a new CUSIP number.
The reverse split was approved on June 23, 2025, by a majority stockholder and aims to ensure compliance with NYSE American's continued listing requirement of maintaining a stock price above $0.10 per share. Fractional shares will be rounded up to the next whole number, and all outstanding securities, including preferred stock, debt, options, warrants, and equity incentive plans, will be proportionally adjusted.
FOXO Technologies Inc. (NYSE American: FOXO) announced that its behavioral health subsidiary, Myrtle Recovery Centers, has secured approval for Scott County Opioid Abatement Funds for a second consecutive year. The funding, effective July 1, 2025, will support care for uninsured patients from Scott County at the company's Oneida, Tennessee facility.
The facility is currently operating at full capacity with a patient waiting list, demonstrating strong demand for its services. Myrtle's CEO Robert Merritt highlighted this as validation of their clinical team's quality of care. FOXO's CEO Seamus Lagan indicated plans for expansion through organic growth and acquisitions, expecting Myrtle to become a significant revenue contributor to FOXO in the future.
FOXO Technologies (NYSE American: FOXO) has designated a new Series E Cumulative Redeemable Secured Preferred Stock to support its acquisition strategy. The Series E Preferred Stock features include a $25.00 per share stated value, 2.5% annual cash dividend (paid semi-annually), 5.0% annual common stock dividend (paid semi-annually), and security interest in FOXO Acquisition Corporation.
The company plans to use this preferred stock as both acquisition currency and for capital raising, with intentions to have it publicly listed with its own trading symbol. CEO Seamus Lagan emphasized this non-dilutive funding mechanism's potential to increase net revenues and cash flow through strategic acquisitions.
FOXO Technologies Inc. (NYSE American: FOXO) announced the expansion of services at its Big South Fork Medical Center in Oneida, Tennessee, to include wound care services starting June 2, 2025. The hospital, which currently serves over 600 emergency room patients and 300 outpatients monthly, will offer both inpatient and outpatient wound care services.
The expansion addresses a growing need for wound care services, particularly for diabetic patients. According to the CDC, as of 2021, over 38 million diabetes patients existed in the U.S., with up to 15% experiencing diabetic foot ulcers. The hospital is currently reconfiguring space and making key clinical hires to support this initiative.
FOXO Technologies (NYSE American: FOXO) announced significant operational achievements for its behavioral health subsidiary, Myrtle Recovery Centers. Since launching in Oneida, Tennessee in August 2023, the facility has:
- Treated over 400 patients
- Provided 5,000+ care days
- Projects 10,000 patient care days by end of 2025
Myrtle's CEO Robert Merritt highlighted the facility's strong reputation in East Tennessee for substance use disorder treatment. FOXO's CEO Seamus Lagan expressed satisfaction with the investment and indicated plans for expansion to additional locations to increase revenue contribution.
FOXO Technologies has completed a 1-for-10 reverse stock split effective April 28, 2025, at 4:01pm Eastern Time. The company's stock, trading under symbol FOXO on NYSE American, will begin post-split trading on April 29, 2025.
Key changes include:
- Common stock consolidation: Every 10 shares will combine into 1 share
- Share count reduction: From 38.7 million to approximately 3.87 million shares
- Par value remains unchanged at $0.0001
- Fractional shares will be rounded up to the next whole number
All outstanding preferred shares, stock options, warrants, and equity incentive plans will be adjusted accordingly. Continental Stock Transfer & Trust Company will serve as the exchange agent, providing instructions to stockholders of record for certificate exchange. Broker-held positions will adjust automatically.
FOXO Technologies (NYSE American: FOXO) has announced a 1-for-10 reverse stock split of its Class A common stock, effective April 28, 2025, at 4:01pm ET. The stock will begin trading on a split-adjusted basis on April 29, 2025, under the same symbol 'FOXO' but with a new CUSIP number.
The reverse split was approved by stockholders at the Annual Meeting on November 29, 2024, with an authorized ratio range of 1:5 to 1:100. The action aims to ensure compliance with NYSE American's continued listing requirement of maintaining a stock price above $0.10.
For every ten shares held, stockholders will receive one share, with fractional shares rounded up to the next whole number. The split will proportionally affect all outstanding stock options, warrants, and equity incentive plans. Continental Stock Transfer & Trust Company will serve as the exchange agent, managing the conversion process for physical certificates and fractional share adjustments.
FAQ
What is the current stock price of FOXO TECHNOLOGIES (FOXO)?
What is the market cap of FOXO TECHNOLOGIES (FOXO)?
